Pitfalls in the diagnosis of Cushing's syndrome

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 8, 2007, Pages 1207-1216

  Vilar, Lucio ^a,g   Freitas, Maria Da Conceição ^b   Faria, Manuel ^c   Montenegro, Renan ^d   Casulari, Luiz Augusto ^e   Naves, Luciana ^e   Bruno, Oscar D ^f  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Getulio Vargas Hospital   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^d FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^e HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^g NONE   (Brazil)

Author keywords

ACTH; Bilateral inferior petrosal sinus sampling; Cushing's syndrome; Dexamethasone suppression test; Hypercortisolism; Midnight serum cortisol; Urinary free cortisol

Indexed keywords

EID: 38649087359     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000800006     Document Type: Review

References (82)

1. Vilar L, Naves LA, Freitas MC, Moura E, Canadas V, Leal E, et al. Endogenous Cushing's syndrome: Clinical and laboratorial features in 73 cases. Arq Bras Endocrinol Metab 2007;51:566-74.
2. rd ed. Rio de Janeiro: Guanabara Koogan, 2006. pp. 397-417.
3. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006;367:1605-17.
4. Newell-Price J, Trainer P, Besser GM, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19:647-72.
5. Findling JW, Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 2005;34:385-402.
6. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434-44.
7. Findling JW, Raff H. Cushing's syndrome: Important issues in diagnosis and management. J Clin Endocrinol Metab 2006;91:3746-53.
8. Meier CA, Biller BMK. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 1997;26:741-62.
9. Findling JW, Raff H. Diagnosis and differential diagnosis of Cushing's syndrome Endocrinol Metab Clin North Am 2001;30:729-47.
10. Mengden T, Hubmann P, Muller J, Greminger P, Vetter W. Urinary free cortisol vs. 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Invest 1992;70:545-8.
11. Nieman LK, Cutler Jr GB. The sensitivity of the urine free cortisol measurement as a screening test for Cushing's syndrome. Program of the 72nd Annual Meeting of The Endocrine Society, Atlanta GA, 1990 (Abstract P-822).
12. Nieman LK. Diagnostic tests for Cushing's syndrome. Ann N Y Acad Sci 2002;970:112-8.
13. Lin CL, Wu TJ, Machacek DA, Jiang NS, Kao PC. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997;82:151-5.
14. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA. Urinary free cortisol excretion in depression. Psychol Med 1976;6:43-50.
15. Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, et al. Factitious Cushing syndrome. J Clin Endocrinol Metab 1996;81:3573-7.
16. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M, Schulte HM. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) 1990;133:279-89.
17. Meikle AW, Findling J, Kushnir MM, Rockwood AL, Nelson GJ, Terry AH. Pseudo-Cushing syndrome caused by fenofibrate interference with urinary cortisol assayed by high-performance liquid chromatography. J Clin Endocrinol Metab 2003;88:3521-4.
18. Findling JW, Pinkstaff SM, Shaker JL, Raff H, Nelson JC. Pseudohypercortisoluria: spurious elevation of urinary cortisol due to carbamazepine. Endocrinologist 1998;8:51-4.
19. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997;34:222-9.
20. Findling JW, Raff H, Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 2004;89:1222-6.
21. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, et al. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2003;88:5299-306.
22. Vilar L, Freitas MC, Canadas V, Moura E, Campos R, Teixeira L, et al. Performance of low-dose dexamethasone suppression tests in obesity and in Cushing's syndrome. Arq Bras Endocrinol Metab 2002;46(suppl. 1):S493.
23. Krieger DT, Allen W, Rizzo F, Krieger HP. Characterization of the normal temporal pattern of plasma cortisol levels. J Clin Endocrinol Metab 1971;32:266-84.
24. Laudat MH, Cerdas S, Fournier C, Guiban D, Guilhaume B, Luton JP. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab 1988;66:343-8.
25. Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1995;43:545-50.
26. Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 1998;83:1163-7.
27. Giraldi FP, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cavagnini F. Specificity of first-line tests for the diagnosis of Cushing's syndrome. Assessment in a large series. J Clin Endocrinol Metab 2007;[Epub ahead of print]
28. Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome. Eur J Endocrinol 2005;153:803-9.
29. Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J Clin Endocrinol Metab 2003; 88:4153-7.
30. Castro M, Elias PC, Quidute AR, Halah FP, Moreira AC. Outpatient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests. J Clin Endocrinol Metab 1999;84:878-82.
31. Yaneva M, Mosnier-Pudar H, Dugue MA, Grabar S, Fulla Y, Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 2004;89:3345-51.
32. Raff H. Role of salivary cortisol determinations in the diagnosis of Cushing syndrome. Curr Opin Endocrinol Diabetes 2004;11:271-5.
33. Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. Elevated latenight salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol 2005;63:642-9.
34. Yanovski JA, Cutler GB Jr., Chrousos GP, Nieman LK. Corticotropin- releasing hormone stimulation following low-dose dexamethasone administration. JAMA 1993;269:2232-8.
35. Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 2006;91:2582-6.
36. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Extensive clinical experience. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-62.
37. Salgado LR, Fragoso MCBV, Knoepfelmacher M, Machado MC, Domenice S, Pereira MAA, et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol 2006;155:725-33.
38. Bruno OD, Rossi MA, Contreras LN, Gomez RM, Galparsoro G, Cazado E, et al. Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome. Acta Endocrinol (Copenh) 1985;109:158-62.
39. Invitti C, Giraldi FP, de Martin M, Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study group of the Italian Society of Endocrinology on the pathophysiology of the hypothalamic-pituitaryadrenal axis. J Clin Endocrinol Metab 1999;84:440-8.
40. Vilar L, Freitas MC, Moura E, Campos R, Leal E, Teixeira L, et al. Cushing's disease caused by macroadenomas - Report of 7 cases. Arq Bras Endocrinol Metab 1996;40(suppl. 2):S221.
41. Aron DC, Raff H, Findling JW. Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 1997;82:1780-5.
42. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler GB Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1993;77:1308-12.
43. Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, et al. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitaryadrenal axis. J Clin Endocrinol Metab 1995;80:412-7.
44. Lindsay JR, Nieman LK. Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am 2005;34:403-21.
45. Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, et al. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 2002;87:1640-5.
46. Reimondo G, Paccotti P, Minetto M, Termine A, Stura G, Bergui M, et al. The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome. Clin Endocrinol (Oxf) 2003;58:718-24.
47. Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G, et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease. Eur J Endocrinol 2000;143:227-34.
48. Malerbi DA, Mendonça BB, Liberman B, Toledo SP, Corradini MC, Cunha-Neto MB, et al. The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clin Endocrinol (Oxf) 1993;38:463-72.
49. Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, Sotiropoulou, et al. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 2002;87:1646-53.
50. De Keyzer Y, Lenne F, Auzan C, Jegou S, Rene P, Vaudry H, et al. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996;97:1311-8.
51. Tsagarakis S, Kaskarelis IS, Kokkoris P, Malagari C, Thalassinos N. The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndrome. Clin Endocrinol (Oxf) 2000;52:355-61.
52. Corrigan DF, Schaaf M, Whaley RA, Czerwinski CL, Earll JM. Selective venous sampling to differentiate ectopic ACTH secretion from pituitary Cushing's syndrome. N Engl J Med 1997;296:861-2.
53. Castinetti F, Morange I, Dufour H, Jaquet P, Conte-Devolx B, Girard N, et al. Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing's syndrome. Eur J Endocrinol 2007;157:271-7.
54. Kaltsas GA, Giannulis MG, Newell-Price J, Dacie JE, Thakkar C, Afshar F, et al. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999;84:487-92.
55. Findling JW, Kehoe ME, Shaker JL, Raff H. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab1991;73:408-13.
56. Yamamoto Y, Davis DH, Nippoldt TB, Young Jr WF, Huston III J, Parisi JE. False-positive inferior petrosal sinus sampling in the diagnosis of Cushing's disease. J Neurosurg 1995;83:1087-91.
57. Swearingen B, Katznelson L, Miller K, Grinspoon S, Waltman A, Dorer DJ, et al. Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab 2004;89:3752-63.
58. Findling JW, Kehoe ME, Raff H. Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent. J Clin Endocrinol Metab 2004;89:6005-9.
59. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, McKeever PE, Krudy AG, et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985;312:100-3.
60. Miller DL, Doppman JL, Peterman SB, Nieman LK, Oldfield EH, Chang R. Neurologic complications of petrosal sinus sampling. Radiology 1992;185:143-7.
61. Blevins LS Jr, Clark RV, Owens DS. Thromboembolic complications after inferior petrosal sinus sampling in patients with Cushing's syndrome. Endocr Pract 1998;4:365-7.
62. Coire CI, Horvath E, Kovacs K, Smyth HS, Ezzat S. Cushing's syndrome from an ectopic pituitary adenoma with peliosis: a histological, immunohistochemical, and ultrastructural study and review of the literature. Endocr Pathol 1997;8:65-74.
63. Vilar L, Azevedo MF, Barisic G, Naves LA. Pituitary incidentalomas. Arq Bras Endocrinol Metab 2005;49:651-6.
64. Krikorian A, Aron D. Evaluation and management of pituitary incidentalomas - revisiting an acquaintance. Nat Clin Pract Endocrinol Metab 2006;2:138-45.
65. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88:5593-602.
66. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004;25:309-40.
67. Findling JW, Doppman JL. Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 1994;23:511-37.
68. Ayala AR, Basaria S, Udelsman R, Westra WH, Wand GS. Corticotropin- independent Cushing's syndrome caused by an ectopic adrenal adenoma. J Clin Endocrinol Metab 2000;85:2903-6.
69. Wajchenberg BL, Mendonça BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, et al. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 1994;15:752-87.
70. Doppman JL, Nieman L, Miller DL, Pass HI, Chang R, Cutler Jr GB, et al. Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. Radiology 1989;172:115-24.
71. Hernandez I, Espinosa-de-los-Monteros AL, Mendoza V, Cheng S, Molina M, Sosa E, et al. Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor. Arch Med Res 2006;37:976-80.
72. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, et al. Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs. CT. AJR Am J Roentgenol 1991;156:39-43.
73. Vilar L, Moura E, Canadas V, Gusmão A, Teixeira L, Campos R, et al. Pituitary incidentaloma in a patient with Cushing's syndrome caused by ectopic ACTH secretion. Arq Bras Endocrinol Metab 2007;51:S253.
74. Loli P, Vignati F, Grossrubatscher E, Dalino P, Possa M, Zurleni F, et al. Management of occult adrenocorticotropin-secreting bronchial carcinoids: limits of endocrine testing and imaging techniques. J Clin Endocrinol Metab 2003;88:1029-35.
75. Tsagarakis S, Christoforaki M, Giannopoulou H, Rondogianni F, Housianakou I, Malagari C, et al. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab 2003;88:4754-8.
76. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, et al. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999;84:1193-202.
77. Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Octreoscan in patients with bronchial carcinoid tumours. Clin Endocrinol (Oxf) 2003;59:793-9.
78. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 2003;88:5808-13.
79. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X, et al. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 1994;78:20-4.
80. Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-DPhe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab 2004;89:2214-21.
81. Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005;90:3392-400.
82. Grossman AB, Kelly P, Rockall A, Bhattacharya S, McNicol A, Barwick T. Cushing's syndrome caused by an occult source: difficulties in diagnosis and management. Nat Clin Pract Endocrinol Metab 2006;2:642-7.